Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

MJ Sarnak, K Amann, S Bangalore… - Journal of the American …, 2019 - jacc.org
Chronic kidney disease (CKD) is a major risk factor for coronary artery disease (CAD). As
well as their high prevalence of traditional CAD risk factors, such as diabetes and …

The key role of phosphate on vascular calcification

M Cozzolino, P Ciceri, A Galassi, M Mangano… - Toxins, 2019 - mdpi.com
Vascular calcification (VC) is common in dialysis and non-dialysis chronic kidney disease
(CKD) patients, even in the early stage of the disease. For this reason, it can be considered …

Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch signaling: Potential mechanism for …

T Nakano, S Katsuki, M Chen, JL Decano, A Halu… - Circulation, 2019 - Am Heart Assoc
Background: Chronic kidney disease (CKD) increases cardiovascular risk. Underlying
mechanisms, however, remain obscure. The uremic toxin indoxyl sulfate is an independent …

Association between triglyceride glucose index, coronary artery calcification and multivessel coronary disease in Chinese patients with acute coronary syndrome

J Wang, X Huang, C Fu, Q Sheng, P Liu - Cardiovascular diabetology, 2022 - Springer
Background Multivessel coronary disease (MVCD) is the common type of coronary artery
disease in acute coronary syndrome (ACS). Coronary artery calcification (CAC) has been …

A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD

Y Sakaguchi, T Hamano, Y Obi, C Monden… - Journal of the …, 2019 - journals.lww.com
Background Develo** strategies for managing coronary artery calcification (CAC) in
patients with CKD is an important clinical challenge. Experimental studies have …

[HTML][HTML] Chronic kidney disease

SR Vaidya, NR Aeddula - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Chronic Kidney Disease - StatPearls - NCBI Bookshelf US flag An official website of the United
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …

Hyperphosphatemia and cardiovascular disease

C Zhou, Z Shi, N Ouyang, X Ruan - Frontiers in Cell and …, 2021 - frontiersin.org
Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range”
are highly associated with increased cardiovascular disease risk and mortality in the general …

Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and …

XR Wang, JJ Zhang, XX Xu, YG Wu - Renal Failure, 2019 - Taylor & Francis
Purpose: To date, the prevalence and prognostic role of coronary artery calcification (CAC)
in patients with chronic kidney disease (CKD) have been investigated in several studies, but …

Fruit and vegetable treatment of chronic kidney disease-related metabolic acidosis reduces cardiovascular risk better than sodium bicarbonate

N Goraya, Y Munoz-Maldonado, J Simoni… - American journal of …, 2019 - karger.com
Background: Current guidelines recommend treatment of metabolic acidosis in chronic
kidney disease (CKD) with sodium-based alkali. We tested the hypothesis that treatment …

Serum calcification propensity and coronary artery calcification among patients with CKD: the CRIC (Chronic Renal Insufficiency Cohort) study

JD Bundy, X Cai, JJ Scialla, MA Dobre, J Chen… - American journal of …, 2019 - Elsevier
Rationale & Objective Coronary artery calcification (CAC) is prevalent among patients with
chronic kidney disease (CKD) and increases risks for cardiovascular disease events and …